ArticleFrontiers in immunology2025

Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson's disease.

Gergana Mincheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.